Drug Shortage Report for RATIO-DOCUSATE SODIUM

Last updated on 2021-01-21 History
Report ID 128327
Drug Identification Number 00870226
Brand name RATIO-DOCUSATE SODIUM
Common or Proper name DOCUSATE SOD 20MG/5ML SYRUP
Company Name TEVA CANADA LIMITED
Market Status MARKETED
Active Ingredient(s) DOCUSATE SODIUM
Strength(s) 20MG
Dosage form(s) SYRUP
Route of administration ORAL ORAL
Packaging size 500ml
ATC code A06AA
ATC description DRUGS FOR CONSTIPATION
Reason for shortage Disruption of the manufacture of the drug.
Anticipated start date
Actual start date 2020-11-11
Estimated end date 2021-01-31
Actual end date 2021-01-20
Shortage status Resolved
Updated date 2021-01-21
Company comments
Health Canada comments
Contact Address 30 NOVOPHARM COURT
TORONTO, ONTARIO
CANADA M1B 2K9
Company contact information

Version History

Click on "Compare" below to view the full report history and compare to other versions.

Version Number Date Updated Language
v6 2021-01-21 French Compare
v5 2021-01-21 English Compare
v4 2021-01-07 French Compare
v3 2021-01-07 English Compare
v2 2020-11-12 French Compare
v1 2020-11-12 English Compare